E.g., 06/11/2021
E.g., 06/11/2021

bioMérieux announces the CE marking of TB IGRA® test on VIDAS®  

24 March, 2021

Today marks World Tuberculosis (TB) Day and bioMérieux, a world leader in the field of in vitro diagnostics, announces the CE marking of its innovative and fully-automated test VIDAS® TB IGRA (Interferon-Gamma Release Assay) to diagnose latent TB infection.

bioMérieux enlarges its pathogen identification capability on VITEK® MS

06 July, 2016

With a database of more than 15,000 strains VITEK® MS improves clinical decision-making for infectious diseases

bioMerieux Receives FDA Clearance for Expanded Use of VIDAS® B•R•A•H•M•S PCT™ Test for Managing Sepsis Patients with Elevated Risk of Mortality

01 July, 2016

Tracking PCT – a biomarker for bacterial infections – over time provides strong indication of likely mortality, enabling physicians to personalize care for high-risk patients

Diagnostics is power